QuidelOrtho to Report Second Quarter 2025 Financial Results
QuidelOrtho (NASDAQ: QDEL), a global provider of in vitro diagnostic technologies, has scheduled its second quarter 2025 financial results announcement for Tuesday, August 5, 2025, after market close.
The company will host a conference call at 2:00 p.m. PT / 5:00 p.m. ET to discuss the results. Investors can access the webcast through QuidelOrtho's investor relations website, or join via phone using specific dial-in numbers. Presentation materials will be available on the company's website concurrent with the call.
QuidelOrtho (NASDAQ: QDEL), fornitore globale di tecnologie diagnostiche in vitro, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per marted矛 5 agosto 2025, dopo la chiusura dei mercati.
L'azienda terr脿 una conference call alle 14:00 PT / 17:00 ET per discutere i risultati. Gli investitori potranno seguire la diretta web tramite il sito dedicato agli investitori di QuidelOrtho o partecipare telefonicamente utilizzando i numeri di accesso specifici. I materiali della presentazione saranno disponibili sul sito aziendale contemporaneamente alla chiamata.
QuidelOrtho (NASDAQ: QDEL), proveedor global de tecnolog铆as de diagn贸stico in vitro, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el martes 5 de agosto de 2025, despu茅s del cierre del mercado.
La compa帽铆a realizar谩 una conferencia telef贸nica a las 2:00 p.m. PT / 5:00 p.m. ET para analizar los resultados. Los inversores podr谩n acceder a la transmisi贸n en vivo a trav茅s del sitio web de relaciones con inversores de QuidelOrtho o unirse por tel茅fono usando n煤meros de marcaci贸n espec铆ficos. Los materiales de la presentaci贸n estar谩n disponibles en el sitio web de la empresa simult谩neamente con la llamada.
QuidelOrtho (NASDAQ: QDEL)電� 觳挫櫢 歆勲嫧 旮办垹鞚� 旮�搿滊矊 鞝滉车鞐呾泊搿滌劀 2025雲� 2攵勱赴 鞛 鞁れ爜 氚滍憸毳� 2025雲� 8鞗� 5鞚� 頇旍殧鞚� 鞛� 毵堦皭 頉勳棎 鞓堨爼頃橁碃 鞛堨姷雼堧嫟.
須岇偓電� 鞓ろ泟 2:00 PT / 5:00 ET鞐� 旎嵓霟办姢 旖滌潉 臧滌禍頃橃棳 鞁れ爜鞚� 雲检潣頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� QuidelOrtho 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃橁卑雮� 韸轨爼 鞝勴檾 鞝戩啀 氩堩樃毳� 靷毄頃� 鞝勴檾搿� 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 氚滍憸 鞛愲電� 旖滉臣 霃欖嫓鞐� 須岇偓 鞗轨偓鞚错姼鞐� 鞝滉车霅� 鞓堨爼鞛呺媹雼�.
QuidelOrtho (NASDAQ : QDEL), fournisseur mondial de technologies de diagnostic in vitro, a programm茅 l'annonce des r茅sultats financiers du deuxi猫me trimestre 2025 pour le mardi 5 ao没t 2025, apr猫s la cl么ture du march茅.
La soci茅t茅 organisera une conf茅rence t茅l茅phonique 脿 14h00 PT / 17h00 ET pour discuter des r茅sultats. Les investisseurs pourront acc茅der au webinaire via le site des relations investisseurs de QuidelOrtho ou participer par t茅l茅phone en utilisant des num茅ros d'appel sp茅cifiques. Les documents de pr茅sentation seront disponibles sur le site de l'entreprise en m锚me temps que l'appel.
QuidelOrtho (NASDAQ: QDEL), ein globaler Anbieter von In-vitro-Diagnostiktechnologien, hat die Ver枚ffentlichung der Finanzergebnisse f眉r das zweite Quartal 2025 f眉r Dienstag, den 5. August 2025, nach B枚rsenschluss geplant.
Das Unternehmen wird um 14:00 Uhr PT / 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren k枚nnen den Webcast 眉ber die Investor-Relations-Website von QuidelOrtho verfolgen oder per Telefon 眉ber spezielle Einwahlnummern teilnehmen. Pr盲sentationsmaterialien werden zeitgleich mit dem Anruf auf der Unternehmenswebsite verf眉gbar sein.
- None.
- None.
Following the release of financial results, QuidelOrtho will hold a conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial results. Interested parties can access the call from the "Events & Presentations" section of the "Investor Relations" page of the Company's website at听. Presentation materials will also be posted to the "Events & Presentations" section of the "Investor Relations" page of the Company's website at the time of the call. Those unable to access the webcast may join the call via phone by dialing 833-470-1428 (domestic) or +1 929-526-1599 (international) and entering Conference ID number 689337.
A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.听
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed 鈥� from home to hospital, lab to clinic.
Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.
Investor Contact:
Juliet Cunningham
Vice President, Investor Relations
[email protected]
Media Contact:
D. Nikki Wheeler
Senior Director, Corporate Communications
[email protected]听
View original content to download multimedia:
SOURCE QuidelOrtho Corporation
FAQ
When will QuidelOrtho (QDEL) report Q2 2025 earnings?
How can investors access QuidelOrtho's Q2 2025 earnings call?
What time is QuidelOrtho's Q2 2025 earnings call?
Where can investors find QuidelOrtho's Q2 2025 earnings presentation materials?
